Hjem › Kreft (alle typer) › Alabama › Birmingham
Kliniske studier for Kreft (alle typer) i Birmingham, AL
31 studier for Kreft (alle typer) søker deltakere på steder i og rundt Birmingham (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Feasibility of a Real-world, Financial Psycho-oncology Intervention to Address Cancer-related Financial Distress
Rekrutterer
- University of Alabama at Birmingham, Birmingham
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekruttererFase 2/3
- The Kirklin Clinic of UAB Hospital, Birmingham
- The University of Alabama at Birmingham, Birmingham
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
RekruttererFase 3
- UAB Medicine - UAB Hospital, Birmingham
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RekruttererFase 3
- Quetzal Site 16, Birmingham
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
RekruttererFase 3
- Birmingham Hematology and Oncology Associates d/b/a Alabama Oncology /ID# 280063, Birmingham
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekruttererFase 2
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
RekruttererFase 2/3
- University of Alabama Birmingham, Birmingham
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RekruttererFase 2
- UAB, Psychiatry and Behavioral Neurology, Birmingham
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
RekruttererFase 1/2
- The University of Alabama at Birmingham ( Site 1005), Birmingham
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RekruttererFase 1
- University of Alabama at Birmingham Cancer Center, Birmingham
Project: Every Child for Younger Patients With Cancer
RekruttererObservasjonsstudie
- Children's Hospital of Alabama, Birmingham
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
RekruttererFase 2
- Childrens Hospital of Alabama, Birmingham
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruttererFase 3
- University of Alabama at Birmingham Cancer Center, Birmingham
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RekruttererFase 2
- 004, Birmingham
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
RekruttererFase 1
- University of Alabama at Birmingham, Birmingham
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Rekrutterer
- University of Alabama at Birmingham, Division of Hematology and Oncology, Birmingham
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
RekruttererFase 1
- GSK Investigational Site, Birmingham
Childhood Cancer Survivor Study
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- University of Alabama at Birmingham/Children's of Alabama, Birmingham
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Rekrutterer
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
Multisite Implementation of COMPRENDO
RekruttererFrivillige helsepersonell ønskes velkommen
- Children's of Alabama/University of Alabama at Birmingham, Birmingham
Leading Healthy Eating and Activity Promotion Program
RekruttererFrivillige helsepersonell ønskes velkommen
- University of Alabama at Birmingham, Birmingham
Video Inspired Discussions About Ethical Outcomes in Pediatrics
Rekrutterer
- Children's of Alabama at Birmingham, Birmingham
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruttererFase 2
- University of Alabama at Birmingham, Birmingham
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Rekrutterer
- University of Alabama at Birmingham, Birmingham
Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
Rekrutterer
- University of Alabama at Birmingham, Birmingham
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
RekruttererObservasjonsstudie
- Alabama Oncology, Birmingham
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
Rekrutterer
- The Kirklin Clinic, Birmingham
GEMINI-NSCLC: NSCLC Biomarker Study
RekruttererObservasjonsstudie
- Alabama Oncology, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Birmingham
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
Rekrutterer
- University of Alabama at Brimingham, Birmingham
Making Healthy Habits Stick
Rekrutterer
- University of Alabama at Birmingham, Birmingham
Kreft (alle typer)-studier i andre byer
- Houston, TX121 studier
- New York City, NY109 studier
- Boston, MA85 studier
- Los Angeles, CA74 studier
- Nashville, TN65 studier
- Philadelphia, PA59 studier
- Washington, DC58 studier
- Durham, NC58 studier
- Chicago, IL51 studier
- Atlanta, GA49 studier
- Seattle, WA49 studier
- Arlington, VA48 studier
Andre studier i Birmingham
- Brystkreft24 studier
- Eggstokkreft23 studier
- Fedme23 studier
- Ikke-småcellet lungekreft22 studier
- Akut myelogen leukemi21 studier
- Multipelt myelom18 studier
- KOLS17 studier
- Kardiovaskulær sykdom17 studier
- Type 2-diabetes16 studier
- Endometriekreft16 studier
- Overvekt16 studier
- Cystisk fibrose16 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.